I think the Vitality Heart Valve could be a revolutionary product! I think they will get European approval for this heart valve later this year. Valve Exchange also has a couple other products in development that look promising.
Right now the company has 13 patents and 8 patent applications pending.
The Vitality Heart Valve combines the best features of a tissue valve with the best features of a mechanical heart valve. Like all tissue valves dangerous daily medicine is not needed.
I think CRY has a very valuable asset here that is not recognized by the market. Check out the their website including the biographies of management and the Medical advisory board! These guys are top draw!
My problem with you position is two fold: First, if CRY can't sell into the US market, which they won't be able to do for several years at best, this becomes a nickel/dime deal. Second, this valve is several and/or /many years away from any possibility for FDA approval. Therefore, it may be a nice dream, but that is likely to be it. SA, the ultimate story spinner, could talk this into a story I supposed; but, meaningful revenues are so far out in time that I give them a $0/share valuation. OK...a $0.05/share valuation. Fancy websites aren't meaningful high margin stable recurring revenues.
In fact it could be argued that this is a perfect example of why SA is not successful. He tries to do things that are too complex for the resources he has.
I'm not blowing SA's horn by any means. What I'm saying is the Valve Exchange looks to me like a potentially very valuable asset that the market has ignored. I think they might have by far the best aortic heart valve in the world! A number of the doctors involved have ties to the Cleveland Clinic! I will bet that the Vitality Heart Valve gets approved in Europe this year. If you think that is not a big deal that's then you have a screw loose.
You don't get 13 patents and have 8 patent applications pending if you are a dummy.
If you are short at these prices that's your problem.